Mel Formica

Mel Formica is a renowned transformation leader in Life Sciences, Biopharmaceuticals, and Digital Healthcare with extensive P&L, operational, and M&A advisory experience.

He is recognized for his innovative strategies in market entry, commercialization, and disruptive technologies aimed at improving the quality of care.

With over 20 years of industry expertise, Mel has held leadership positions at esteemed companies like Evidera, Takeda Pharmaceuticals, Amgen Inc., IMS Health, and Abbot Laboratories across various regions globally.

He excels in clinical research, marketing, strategic consulting, value & access, and evidence generation, making him a sought-after leader for C-Suites and innovative companies worldwide.

Mel is highly regarded for his pioneering concepts, biopharmaceutical product launches, and organizational models that enhance efficiency and drive business growth.

His academic background includes a Ph.D. in Medicine from the University of Melbourne, post-doctoral training at Columbia University, and an Executive MBA from Pace University's Lubin School of Business.

Furthermore, Mel has co-founded the BCG Market Access Roundtable and the LSE Market Access Academy, showcasing his commitment to transforming the industry.

He has also served in various capacities in esteemed institutions like Columbia University and has been featured in numerous industry and scientific publications.